Scientific Advisory Board
Gail K. Naughton, Ph.D., Head, Dr. Naughton contributes invaluable knowledge and focus to Theregen's vascular and cardiovascular product development efforts. She is a world-recognized pioneer in cell-based regenerative medicine and holds more than 80 patents, including several in Theregen's IP portfolio. She has received a National Inventor of the Year award for her pioneering work in tissue engineering. She is currently Dean, School of Business Administration, San Diego State University, and serves on numerous advisory boards and boards of directors for both commercial and non-profit organizations.
Robert S. Kellar, Ph.D., Member, brings extensive experience in research and product development for FDA regulated products. Currently, Dr. Kellar is the Vice President for Research and Development at Histogen, a regenerative medicine company in San Diego, CA. He is also co-owner and President of Development Engineering Sciences, a firm based in Flagstaff, Arizona. Dr. Kellar's experience in the biomedical industry includes prior positions with W.L. Gore & Associates and Advanced Tissue Sciences, where he was involved with commercial worldwide management of research, product development, business, marketing, and sales. Dr. Kellar holds an Adjunct Professor Faculty position in Mechanical Engineering at Northern Arizona University and serves as a Board member for commerical and non-profit organizations.
Robert C. Robbins, M.D., Member, chairs the Department of Cardiothoracic Surgery of Stanford University.s School of Medicine, where he also serves as Director of the Stanford Cardiovascular Institute and Co-Director of the Cardiac Clinical Center at Stanford University Hospital. Dr. Robbins has extensive research experience in the area of congestive heart failure. He is a Fellow of the American Heart Association, American College of Cardiology and the American College of Surgery.
Stuart K. Williams, Ph.D., Member, brings extensive experience in cell-based regenerative medicine and cardiovascular therapeutics in his capacity as consultant and member of Theregen's Scientific Advisory Board. Dr.Williams is the scientific director of the Cardiovascular Innovation Institute, a partnership between the University of Louisville and Jewish Hospital & St. Mary's Health Care, and a professor in the Department of Surgery. He has extensive expertise in cardiovascular applications of biomedical devices and cell-based therapeutics. Dr. Williams serves as a Board member or scientific advisor to several companies.
Clinical Advisory Board
Frank Giordano, M.D.Assistant Professor of Medicine
(Cardiovascular Medicine),
Yale University School of Medicine
Bartley Griffith, M.D.
Professor of Surgery and Chief,
Division of Cardiac Surgery,
University of Maryland Medical Center
Kenneth Margulies, M.D.
Associate Professor of Medicine,
Hospital of the University of Pennsylvania,
Cardiovascular Medicine Division
Robert S. Poston, M.D.
Chief of Cardiac Surgery, Boston Medical Center,
Associate Professor of Cardiothoracic Surgery,
Boston University Medical Center
Albert Sinusas, M.D.
Chief of Nuclear Cardiology,
Professor of Diagnostic Radiology and Internal Medicine,
Yale University School of Medicine
George Tellides, M.D.
Associate Professor, Cardiothoracic Surgery,
Yale University School of Medicine
Hoang Thai, M.D.
Assistant Professor of Cardiology,
Southern Arizona VA Health Care System
Renu Virmani, M.D.
President and Medical Director, CV Path Institute, Inc.
Y. Joseph Woo, M.D.
Assistant Professor of Surgery and Director,
Minimally Invasive and Robotic Cardiac Surgery Program,
University of Pennsylvania School of Medicine